Investor Builds $6 Million Position in Surging Chemicals Name Beating the S&P 500 by Nearly 40 Points

4 days ago 5

Jonathan Ponciano, The Motley Fool

Wed, March 18, 2026 astatine 9:00 AM CDT 4 min read

On February 17, 2026, EVR Research disclosed a caller presumption successful Ingevity (NYSE:NGVT), acquiring 100,000 shares worthy $5.92 million.

In a U.S. Securities and Exchange Commission (SEC) filing dated February 17, 2026, EVR Research reported initiating a caller presumption successful Ingevity by purchasing 100,000 shares during the 4th quarter. The fund's quarter-end presumption successful NGVT was valued astatine $5.92 million, reflecting the afloat size of the caller stake.

This was a caller presumption for the fund, representing 3.19% of its $185.31 cardinal successful reportable U.S. equity assets arsenic of December 31, 2025.
Top holdings aft the filing:
- NYSE:DAN: $17.34 cardinal (9.4% of AUM)
- NYSE:WKC: $17.34 cardinal (9.4% of AUM)
- NYSE:CPS: $12.31 cardinal (6.6% of AUM)
- NYSE:GEF: $11.85 cardinal (6.4% of AUM)
- NYSE:MEC: $11.33 cardinal (6.1% of AUM)
As of Wednesday, Ingevity shares were priced astatine $68.56, up 56% implicit the past twelvemonth and good outperforming the S&P 500’s astir 19% summation successful the aforesaid period.

Metric

Value

Price (as of Monday)	$68.56
Market capitalization	$2.5 billion
Revenue (TTM)	$1.17 billion
Net income (TTM)	($150.3 million)

EVR Research produces specialty chemicals and activated c materials, with cardinal products including hardwood-based activated c for emissions power and chemicals derived from crude gangly lipid and lignin.
The institution operates a dual-segment concern model: Performance Materials generates gross from engineered c products for automotive and concern applications, portion Performance Chemicals targets pavement technologies, concern specialties, and engineered polymers.
It serves automotive OEMs, concern manufacturers, and infrastructure customers crossed North America, Asia Pacific, Europe, the Middle East, Africa, and South America.

Ingevity is simply a specialty chemicals institution with a planetary footprint and a absorption connected engineered c solutions and show chemicals. The institution leverages proprietary technologies to code emissions control, concern processing, and infrastructure needs, supporting divers extremity markets.

EVR Research conscionable added targeted cyclical vulnerability astatine a clip erstwhile investors are getting much selective astir wherever maturation really shows up successful the existent economy. Within a portfolio already tilted toward concern and materials names, this presumption fits cleanly alongside holdings tied to manufacturing, infrastructure, and car demand, alternatively than high-multiple tech bets.

Ingevity’s activated c and specialty chemicals businesses are tied straight to emissions standards, infrastructure spending, and concern production, which thin to clasp up amended than expected erstwhile economical momentum stabilizes, and the company’s caller show reflects that, with shares up astir 56% implicit the past twelvemonth and comfortably beating the broader market. In its latest net report, Ingevity pointed to adjusted EBITDA of $373 cardinal past year, which was accordant with 2024 levels contempt broader uncertainty tied to tariffs and proviso concatenation disruptions.

At conscionable implicit 3% of assets, this isn’t rather a apical holding, but it does suggest condemnation successful the stock. Ultimately, it seems this is simply a durable stake for an capitalist focused connected conscionable that.

Read Entire Article